Correlation Between Cyxone AB and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyxone AB and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyxone AB and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyxone AB and Xvivo Perfusion AB, you can compare the effects of market volatilities on Cyxone AB and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyxone AB with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyxone AB and Xvivo Perfusion.

Diversification Opportunities for Cyxone AB and Xvivo Perfusion

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cyxone and Xvivo is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Cyxone AB and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and Cyxone AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyxone AB are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of Cyxone AB i.e., Cyxone AB and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between Cyxone AB and Xvivo Perfusion

Assuming the 90 days trading horizon Cyxone AB is expected to generate 10.65 times more return on investment than Xvivo Perfusion. However, Cyxone AB is 10.65 times more volatile than Xvivo Perfusion AB. It trades about 0.01 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about -0.15 per unit of risk. If you would invest  3.90  in Cyxone AB on August 29, 2024 and sell it today you would lose (1.35) from holding Cyxone AB or give up 34.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cyxone AB  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
Cyxone AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyxone AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyxone AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cyxone AB and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyxone AB and Xvivo Perfusion

The main advantage of trading using opposite Cyxone AB and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyxone AB position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind Cyxone AB and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences